Dr Reddys Laboratories (RDY) EBITDA Margin Growth (1y) (2010 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.72 Bn | 39.07 Bn | 2.15 Bn | -1,647.00 |
| 2 | Viatris | 19.14 Bn | 18.26 Bn | 1.46 Bn | -634.00 |
| 3 | Dr Reddys Laboratories | 9.89 Bn | 9.71 Bn | 396.53 Mn | -1,576.00 |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.34 Bn | 334.51 Mn | 93.00 |
| 5 | Bausch Health Companies | 2.33 Bn | 494.50 Mn | 2.10 Bn | 840.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -12,485.00 |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | 864.00 |
| 8 | Amphastar Pharmaceuticals | 994.43 Mn | 704.31 Mn | 93.47 Mn | -258.00 |
| 9 | Fennec Pharmaceuticals | 399.34 Mn | 358.09 Mn | 17.15 Mn | 3,802.00 |
| 10 | RedHill Biopharma | 178.33 Mn | 178.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,576.00 |
| Mar 31, 2026 | -1,898.00 |
| Dec 31, 2025 | -608.00 |
| Sep 30, 2025 | -200.00 |
| Jun 30, 2025 | -291.00 |
| Mar 31, 2025 | -37.00 |
| Dec 31, 2024 | -154.00 |
| Sep 30, 2024 | -407.00 |
| Jun 30, 2024 | -260.00 |
| Mar 31, 2024 | -502.00 |
| Dec 31, 2023 | 425.00 |
| Sep 30, 2023 | 170.00 |
| Jun 30, 2023 | 255.00 |
| Mar 31, 2023 | 2,335.00 |
| Dec 31, 2022 | 923.00 |
| Sep 30, 2022 | 687.00 |
| Jun 30, 2022 | 244.00 |
| Mar 31, 2022 | -1,063.00 |
| Dec 31, 2021 | -564.00 |
| Sep 30, 2021 | 1,295.00 |